Clinical Trial Update: Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluated curcumin as add-on therapy for schizophrenia, examining quality of life and IL-1β levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Rinvil Renaldi | Conditions: Schizophrenia, Psychotic Disorders | NA | Status: COMPLETED